These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5067205)

  • 1. Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.
    Pecorari D; Ragni N; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:278-8. PubMed ID: 5067205
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Buniva G; Cattò G; Chierichetti S; Granata D; Manieri G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:258-6. PubMed ID: 4553233
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.
    Fumagalli G; Mazzola C; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:274-8. PubMed ID: 5067204
    [No Abstract]   [Full Text] [Related]  

  • 4. Survey of the biological properties of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370), a novel agent in the class of anti-inflammatory drugs.
    Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:249-5. PubMed ID: 5067202
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Ghiringhelli F; Mazzi C; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:268-7. PubMed ID: 5067203
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.
    Seghezzi R; Borri P; Chierichetti S; Ferrari P
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:272-4. PubMed ID: 4553236
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.
    Pasotti C; Barbieri C; Buniva G; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:262-5. PubMed ID: 4553234
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F; Ongari R; Carazzi R; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationships in anti-inflammatory compounds chemically related to 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Pala G; Mantegani A; Donetti A; Lumachi B; Marazzi-Uberti E; Casadio S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:174-7. PubMed ID: 5067188
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
    Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
    [No Abstract]   [Full Text] [Related]  

  • 11. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
    Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 5. Activity on acute experimental synovitis in dogs.
    Lumachi B
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:202-4. PubMed ID: 5067193
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 6. Activity on polyarthritis induced in rats by Freund's adjuvant.
    Lumachi B
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:204+. PubMed ID: 5067194
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. Enzyme induction and interaction with other drugs in the rat.
    Coppi G; Vidi A; Vanoni PC; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:242-6. PubMed ID: 4111897
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
    Bianchi C; Lumachi B; Marazzi-Uberti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial in acute and subacute inflammations of aspecific etiology involving the pelvis, with a new synthetic product: "tantum biotic"].
    Ponte PL; Cacciari P
    Minerva Ginecol; 1969 Oct; 21(19):1329-32. PubMed ID: 5407220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benzidamine in vaginal surgery. Evaluation of its usefulness in the postoperative period].
    Gutiérrez Murillo E; López Rosales C
    Ginecol Obstet Mex; 1972 May; 31(187):475-83. PubMed ID: 4556507
    [No Abstract]   [Full Text] [Related]  

  • 20. [1st experiences in urology with a new non-steroid anti-inflammatory agent].
    Rocca Rossetti S; Oggianu F; Chierichetti S
    Minerva Urol; 1973; 25(6):276-84. PubMed ID: 4781118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.